GLP-1 Safety Information

Medication-related programs require clinical review by an independent licensed provider. This page highlights common risk areas, important warnings, and when to seek urgent medical attention. It is not a substitute for medical advice or the provider's prescribing information. Who should not use GLP-1 treatment without provider approval • Anyone with a personal or family history of medullary thyroid carcinoma (MTC) • Anyone with Multiple Endocrine Neoplasia syndrome type 2 (MEN2) • Anyone with a known serious allergic reaction to the active medication or its ingredients • Anyone who is pregnant, trying to become pregnant, or breastfeeding should discuss risks and alternatives with the prescribing clinician before treatment Tell the provider before treatment if you have a history of • Pancreatitis or severe abdominal pain • Gallbladder disease or gallstones • Kidney problems, dehydration, or repeated vomiting • Diabetic retinopathy or major vision changes • Other prescription medicines that can affect blood sugar Common side effects • Nausea • Vomiting • Diarrhea • Constipation • Abdominal pain or indigestion • Reduced appetite Seek urgent medical care if you develop • Severe or persistent abdominal pain, especially if it radiates to the back • Signs of a serious allergic reaction such as swelling, trouble breathing, or widespread rash • Severe dehydration, fainting, or inability to keep fluids down • Symptoms that feel rapidly worsening or unsafe after a dose Compounded medication caution GLP-1 medications, when prescribed, may be compounded formulations prepared by a licensed partner compounding pharmacy. Compounded medications are not reviewed by the FDA for safety, effectiveness, or quality, and are not equivalent or interchangeable with FDA-approved brand-name medications. Follow the dispensing instructions carefully and ask the pharmacy or provider to confirm the exact dose and injection technique. LYT Health Management LLC does not prescribe or dispense medication. Independent providers determine eligibility, clinical appropriateness, and prescribing decisions.